Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhaled Medications01:23

Inhaled Medications

702
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
702
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
1.7K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

196
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
196
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

1.0K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.0K
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

3.0K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
3.0K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

235
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
235

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterization of Pulmonary Dysfunction in Systemic Juvenile Idiopathic Arthritis Using Xenon and Proton MRI.

Pediatric pulmonology·2026
Same author

Recommendations From the Blue Ribbon Panel on Fluoroscopy Safety.

Journal of the American College of Radiology : JACR·2026
Same author

Pediatric pulmonary nodules: current state of knowledge, AI applications, and future directions.

Pediatric radiology·2025
Same author

Magnetic resonance imaging for suspected perianal Crohn's disease in children: a multi-reader agreement study.

European radiology·2025
Same author

Neonatal and Pediatric Pulmonary Vascular Disease.

Radiologic clinics of North America·2025
Same author

Allogeneic haematopoietic stem-cell transplantation for children with refractory systemic juvenile idiopathic arthritis and associated lung disease: outcomes from an international, retrospective cohort study.

The Lancet. Rheumatology·2024

Related Experiment Video

Updated: Jan 10, 2026

A Minimally Invasive Method for Intratracheal Instillation of Drugs in Neonatal Rodents to Treat Lung Disease
04:21

A Minimally Invasive Method for Intratracheal Instillation of Drugs in Neonatal Rodents to Treat Lung Disease

Published on: August 4, 2021

6.8K

Medication-induced lung disease in children.

Andrew H Schapiro1,2, Kristen L Ruff3,4, R Paul Guillerman3,4

  • 1Department of Radiology, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH, 45229, USA. andrew.schapiro@cchmc.org.

Pediatric Radiology
|November 25, 2025
PubMed
Summary
This summary is machine-generated.

Pediatric medication-induced lung disease, though rare, poses significant risks. Recognizing specific CT patterns aids radiologists in early diagnosis and management of this serious condition.

Keywords:
ChildrenComputed tomographyDrug-inducedLung diseaseMedication-induced

More Related Videos

Direct Intrabronchial Administration to Improve the Selective Agent Deposition Within the Mouse Lung
07:10

Direct Intrabronchial Administration to Improve the Selective Agent Deposition Within the Mouse Lung

Published on: May 20, 2019

14.4K
Inducing Acute Lung Injury in Mice by Direct Intratracheal Lipopolysaccharide Instillation
11:07

Inducing Acute Lung Injury in Mice by Direct Intratracheal Lipopolysaccharide Instillation

Published on: July 6, 2019

26.5K

Related Experiment Videos

Last Updated: Jan 10, 2026

A Minimally Invasive Method for Intratracheal Instillation of Drugs in Neonatal Rodents to Treat Lung Disease
04:21

A Minimally Invasive Method for Intratracheal Instillation of Drugs in Neonatal Rodents to Treat Lung Disease

Published on: August 4, 2021

6.8K
Direct Intrabronchial Administration to Improve the Selective Agent Deposition Within the Mouse Lung
07:10

Direct Intrabronchial Administration to Improve the Selective Agent Deposition Within the Mouse Lung

Published on: May 20, 2019

14.4K
Inducing Acute Lung Injury in Mice by Direct Intratracheal Lipopolysaccharide Instillation
11:07

Inducing Acute Lung Injury in Mice by Direct Intratracheal Lipopolysaccharide Instillation

Published on: July 6, 2019

26.5K

Area of Science:

  • Pediatric Pulmonology
  • Radiology
  • Clinical Pharmacology

Background:

  • Medication-induced lung disease (MILD) in children is uncommon but serious.
  • It can significantly impact patient morbidity, mortality, and treatment plans.
  • Certain drug classes are frequently associated with MILD.

Purpose of the Study:

  • To review medication classes linked to MILD in pediatric patients.
  • To outline clinical diagnosis and management strategies for MILD.
  • To highlight the role of radiologists in identifying MILD through CT findings.

Main Methods:

  • Literature review of MILD in pediatric populations.
  • Analysis of common medication categories implicated in MILD.
  • Correlation of MILD with characteristic computed tomography (CT) patterns.

Main Results:

  • MILD is associated with specific medication categories.
  • Distinct CT patterns are observed in pediatric MILD.
  • Radiologists play a crucial role in early detection.

Conclusions:

  • Early recognition of MILD by radiologists is vital.
  • Understanding CT manifestations aids in timely diagnosis.
  • Multidisciplinary approaches improve MILD management in children.